N/A
N=23
PET Imaging Study of Recovered Anorexics
Anorexia Nervosa
Bottom Line
View on ClinicalTrials.gov: NCT00603018 ↗Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Sep 2016
Primary outcome: Primary: Serotonin Receptor 1A Binding Potential In Regions of Interest (ROI) Accounting for Binding Potential in a Region Without Serotonin 1A Receptors — 5.97; 5.89; 6.66; 6.91 mL/cm^3
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Fluoxetine (Drug)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Pittsburgh
- Primary completion
- Dec 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Serotonin Receptor 1A Binding Potential In Regions of Interest (ROI) Accounting for Binding Potential in a Region Without Serotonin 1A Receptors |
5.97; 5.89; 6.66; 6.91; 5.91; 6.29 | — |
Summary
Several studies in the past suggest that individuals who have or had anorexia nervosa may have alterations in brain serotonin. Serotonin seems to play an important role in regulating anxiety, mood, and other symptoms found in anorexia nervosa. We will be using a technology called Positron Emission Tomography (PET), which is a method used to take pictures of the body, in this case, the brain. Study participants will undergo two baseline PET scans on the first day of the study. The women who have recovered from anorexia will then be given a medication called fluoxetine (also know as Prozac) to take for 8 weeks. At the end of the 8th week, they will return for a third PET scan. By comparing the brain scans, before and after fluoxetine treatment, we can understand more about how treatment with fluoxetine affects the serotonin receptors in the brain. We will be comparing brain serotonin system in women who have recovered from anorexia before and after medication in order to gain a better understanding of changes in the serotonin system associated with eating disorders. This study may help shed light on how to make fluoxetine a more effective treatment for anorexia nervosa.
Eligibility Criteria
Inclusion Criteria
- Recovered from Anorexia Nervosa
- Not taking medication for emotional problems
- Regular menstrual cycle
Exclusion Criteria
- Women who are pregnant or nursing
- Psychoactive medications in the past 30 days
- Neurological disorders.
Data sourced from ClinicalTrials.gov (NCT00603018). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.